Cargando…

Bevacizumab resistance in breast cancer: are neuropilins the key?

Detalles Bibliográficos
Autores principales:	Staton, CA, Yang, Z, Reed, MWR, Brown, NJ
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2008
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3300778/ http://dx.doi.org/10.1186/bcr1959

Ejemplares similares

Role of macrophages in breast cancer angiogenesis in vivo
por: Brown, NJ, et al.
Publicado: (2006)

Assessment of angiogenesis in the hyperplasia preinvasive, invasive breast carcinoma sequence
por: Bluff, JE, et al.
Publicado: (2008)

Expression of neuropilin-1 on in vivo induced regulatory T cells
por: Nirschl, Christopher J, et al.
Publicado: (2013)

Elucidating the role of Neuropilin-1 in intra-tumoral regulatory T cell stability
por: Overacre, Abigail E, et al.
Publicado: (2015)

Circulating epithelial tumor cells in patients with metastatic breast cancer treated with bevacizumab
por: Manso, L, et al.
Publicado: (2009)

Neuropilin-1 expressing melanoma cells as a model to study the aggressiveness of metastatic melanoma
por: Ruffini, Federica, et al.
Publicado: (2015)

Intensivist-led on-call service: key step in mortality reduction
por: Harris, NJ, et al.
Publicado: (2011)

Inhibitor of apoptosis proteins as a therapeutic target in breast cancer
por: Foster, FM, et al.
Publicado: (2008)

Breast cancer follow-up: a focus group and interview study
por: Hughes, CA, et al.
Publicado: (2006)

Future role of bevacizumab in breast cancer
por: Conte, PF, et al.
Publicado: (2009)

Current clinical use of the [(18)F]FDG PET/CT in breast cancer patients: an audit of local referral patterns
por: Laurence, NJ, et al.
Publicado: (2010)

Epigenetic targeting of neuropilin-1 prevents bypass signaling in drug-resistant breast cancer
por: Abdullah, Ammara, et al.
Publicado: (2020)

Prognostic value of a high level of circulating endothelial cells in patients with HER2-recurrent or metastatic breast cancer treated with bevacizumab in combination with paclitaxel and gemcitabine as first-line therapy
por: Manso, L, et al.
Publicado: (2011)

Molecular prediction of tamoxifen resistance in breast cancer
por: Kok, M, et al.
Publicado: (2005)

Efficacy and safety of the administration of bevacizumab in combination with first-line chemotherapy for the treatment of advanced breast carcinoma: ATHENA MO19391 study results in Spanish patients
por: Ciruelos, EM, et al.
Publicado: (2009)

Correction: Epigenetic targeting of neuropilin-1 prevents bypass signaling in drug-resistant breast cancer
por: Abdullah, Ammara, et al.
Publicado: (2023)

Assessing the functional role of caspase-8 gene variants in breast cancer
por: Rigas, SH, et al.
Publicado: (2010)

Downregulation of 15-hydroxyprostaglandin dehydrogenase in hormone-resistant breast cancer
por: Cummings, M, et al.
Publicado: (2008)

Characterising an aromatase inhibitor resistant breast cancer cell line
por: Harris, E, et al.
Publicado: (2012)

microRNA and protein expression in breast cancer formalin-fixed paraffin-embedded samples
por: Gámez-Pozo, A, et al.
Publicado: (2011)

Cell differentiation and dominant signaling pathway signatures in the molecular classification of human breast cancer cell lines
por: Wilson, CA, et al.
Publicado: (2005)

Altered signaling in anti-estrogen-resistant human breast cancer cells
por: Lykkesfeldt, AE, et al.
Publicado: (2005)

P083 Age of Nap Cessation and Short-term Social-Emotional Functioning in Early Childhood
por: Loeffler, A, et al.
Publicado: (2021)

Differential venous oxygen return: a key factor of differential hypoxia in venoarterial extracorporeal membrane oxygenation
por: Hou, X, et al.
Publicado: (2015)

Role of CASP8 D302H and other apoptosis gene variants in breast cancer
por: Mistry, SH, et al.
Publicado: (2006)

Quantitative proteomics reveals proteins associated with radiotherapy resistance in breast cancer cells
por: Smith, L, et al.
Publicado: (2008)

Alpha-1 antitrypsin genotypes in breast cancer patients
por: El-Akawi, Z, et al.
Publicado: (2005)

Reproducibility of molecular portraits in early stage breast cancer
por: Nuyten, DSA, et al.
Publicado: (2005)

Zinc transporter HKE4 as a new target in antihormone resistance of breast cancer
por: Taylor, KM, et al.
Publicado: (2008)

Inactivation of the retinoblastoma tumour suppressor pathway in premenopausal breast cancer is associated with resistance to tamoxifen
por: Lehn, S, et al.
Publicado: (2009)

Immortalization-associated gene signature in breast cancer
por: Dairkee, SH, et al.
Publicado: (2005)

MKS1 interacts with components of the ubiquitin-proteasome pathway to regulate ciliogenesis and multiple signalling pathways
por: Wheway, G, et al.
Publicado: (2012)

Dysregulated metabolism and the regulation of aromatase in breast adipose stromal cells in obesity and cancer
por: Samarajeewa, Nirukshi U, et al.
Publicado: (2012)

Quantitative proteomics reveals novel proteins and central pathways associated with endocrine resistance in breast cancer
por: Løkkegaard, S, et al.
Publicado: (2011)

Communication is key: an innovative multidisciplinary approach to communication of regional antimicrobial resistance surveillance data to hospital microbiologists in North East England
por: Howard, SJ
Publicado: (2015)

Identification of proteins associated with radiotherapy resistance in breast cancer cells: a combined proteomic and microarray screening approach
por: Smith, L, et al.
Publicado: (2008)

Exome sequencing identifies somatic point mutations associated with acquired endocrine resistance in breast cancer cell lines
por: Ehlers, Natasja S, et al.
Publicado: (2012)

Physiological changes after fluid bolus therapy in sepsis: a systematic review of the contemporary literature
por: Glassford, NJ, et al.
Publicado: (2014)

Antiviral prophylaxis inhibits cytomegalovirus reactivation in critical illness
por: Cowley, NJ, et al.
Publicado: (2015)

Nestin and collagen triple helix repeat containing 1 in breast cancer progression
por: Kharaishvili, G, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_2aa4gfbmms6v94ekpb7nej43c6